Blue Flower


  • Shanta gives an invited lecture in Cancer Control Research Program meeting at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States, September 27, 2021. Link
  • Shanta gives an invited lecture in Fall 2021 chemistry department seminar series at the Missouri University of Science and Technology, Missouri, United States, September 20, 2021. Link
  • Our recently accepted work in Biomacromolecules, on orally administrable dual targeted nanoformulations for SARS-CoV-2 associated kidney damage was available online. Congratulations Team!
  • Shanta gives an invited lecture in RCB Webinar Series at the Regional Centre for Biotechnology, Haryana, Indian, August 27 2021. Link
  • Nature Reviews Materials, Newswise and Sciencenewsnet and various other news agencies highlights our recent work on blood-brain-barrier crossing nanoparticles as a drug delivery system that can reduce HIV viral reservoirs and reduce inflammation and oxidative stress in the brain
  • Shrita, Bapu, Subham and Anuj present posters on their work at the 2021 CRS Virtual Annual Meeting, July 25-29, 2021
  • Dhar and Kolishetti labs in collaboration with Nair and Toborek labs developed a nanotherapeutic platform for neuroHIV and drugs of abuse related complications which is in press for a publication in ACS Nano. A true multi team effort which included scientists from different career levels. We hope that this work will help the scientific community with some new insights for HIV therapy. Congratulations Team! Link
  • Shanta gives an invited lecture at the Terasaki Institute, California, United States, July 21 2021. Link
  • Shanta has been admitted as a Fellow of the Royal Society of Chemistry. Congratulations Dr. Shanta Dhar, FRSC!
  • Shanta becomes elected full member of Sigma Xi, The Scientific Research Honor Society
  • Non-provisional patent on "Orally administrable nano-​medicine for viral diseases" is published